4-[4-[2-(difluoromethyl)-4-methoxybenzimidazol-1-yl]-6-morpholin-4-yl-1,3,5-triazin-2-yl]aniline结构式
|
常用名 | 4-[4-[2-(difluoromethyl)-4-methoxybenzimidazol-1-yl]-6-morpholin-4-yl-1,3,5-triazin-2-yl]aniline | 英文名 | 4-[4-[2-(difluoromethyl)-4-methoxybenzimidazol-1-yl]-6-morpholin-4-yl-1,3,5-triazin-2-yl]aniline |
|---|---|---|---|---|
| CAS号 | 1246203-34-8 | 分子量 | 453.445 | |
| 密度 | 1.5±0.1 g/cm3 | 沸点 | 705.5±70.0 °C at 760 mmHg | |
| 分子式 | C22H21F2N7O2 | 熔点 | N/A | |
| MSDS | N/A | 闪点 | 380.5±35.7 °C |
| 英文名 | 4-[4-[2-(difluoromethyl)-4-methoxybenzimidazol-1-yl]-6-morpholin-4-yl-1,3,5-triazin-2-yl]aniline |
|---|---|
| 英文别名 | 更多 |
| 密度 | 1.5±0.1 g/cm3 |
|---|---|
| 沸点 | 705.5±70.0 °C at 760 mmHg |
| 分子式 | C22H21F2N7O2 |
| 分子量 | 453.445 |
| 闪点 | 380.5±35.7 °C |
| 精确质量 | 453.172485 |
| PSA | 104.21000 |
| LogP | 2.13 |
| InChIKey | DOJXCIFLJWOVSY-UHFFFAOYSA-N |
| SMILES | COc1cccc2c1nc(C(F)F)n2-c1nc(-c2ccc(N)cc2)nc(N2CCOCC2)n1 |
| 蒸汽压 | 0.0±2.2 mmHg at 25°C |
| 折射率 | 1.700 |
|
~86%
4-[4-[2-(difluo... 1246203-34-8 |
| 文献:PATHWAY THERAPEUTICS INC.; REWCASTLE, Gordon, William; GIDDENS, Anna, Claire; GAMAGE, Swarnalatha, Akuratiya Patent: WO2012/44641 A1, 2012 ; Location in patent: Page/Page column 46; 82-84 ; WO 2012/044641 A1 |
|
~%
4-[4-[2-(difluo... 1246203-34-8 |
| 文献:PATHWAY THERAPEUTICS INC.; REWCASTLE, Gordon, William; GIDDENS, Anna, Claire; GAMAGE, Swarnalatha, Akuratiya Patent: WO2012/44641 A1, 2012 ; WO 2012/044641 A1 |
| Benzenamine, 4-[4-[2-(difluoromethyl)-4-methoxy-1H-benzimidazol-1-yl]-6-(4-morpholinyl)-1,3,5-triazin-2-yl]- |
| 4-(4-(2-(difluoromethyl)-4-methoxy-1H-benzo[d]imidazol-1-yl)-6-morpholino-1,3,5-triazin-2-yl)aniline |
| 4-(4-(2-(difluoromethyl)-4-methoxy-1H-benzimidazol-1-yl)-6-(4-morpholinyl)-1,3,5-triazin-2-yl)aniline |
| 4-{4-[2-(Difluoromethyl)-4-methoxy-1H-benzimidazol-1-yl]-6-(4-morpholinyl)-1,3,5-triazin-2-yl}aniline |